CALIPHARMS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | 0.00% |
| 2018 | CaliPharms, Inc. Launches a New CBD Muscle & Joint Relief Roll On Gel | CI |
| 2018 | Joe Pavlik Joins the Advisory Board of CaliPharms, Inc | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Alternative Medicine
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 13.88K | - | - | - | - | - | |
| 5.36B | ||||||
| 3.42B | ||||||
| 2.98B | - | - | ||||
| 2.6B | ||||||
| 2.27B | - | - | - | - | - |
- Stock Market
- Equities
- KGET Stock
- Charts CaliPharms, Inc.
- Sector Chart
